Ambu recently announced the introduction of SureSight Mobile, a portable video laryngoscope solution that expands and brings next-level flexibility to Ambu’s video laryngoscope portfolio.
Designed to be robust, reliable, and durable, the SureSight Mobile features an integrated screen without the need for separate monitors or cables. This all-in-one design enables clinicians to perform emergent and unplanned intubations swiftly and confidently in demanding environments – whether in an ambulance, emergency room, or remote location – making the SureSight Mobile a solution targeted for both pre-hospital and hospital settings. This versatile solution delivers high-quality imaging, empowering clinicians to not only visualize the airway with clarity but also seamlessly document and review the intubation process.
“There is now overwhelming evidence that video laryngoscopy enhances both the safety and efficacy of tracheal intubation compared with direct laryngoscopy. The recently published DAS 2025 Intubation Guidelines recommend that video laryngoscopes be used as the first-line approach for tracheal intubation whenever feasible. The launch of the SureSight Mobile is therefore extremely timely, enabling universal access to video laryngoscopy for all intubations across the hospital environment,” said Dr. Imran Ahmad, consultant anesthetist, Guy’s & St Thomas’ NHS Foundation Trust, London, UK.
Expanding and leveraging Ambu’s video laryngoscope portfolio
In the U.S., the video laryngoscope market represents more than $600 billion and is growing 15-20% annually. Today, around 50% of all endotracheal intubations are performed with a video laryngoscope, making it the preferred intubation method across clinical settings. To support this development, Ambu’s expanded video laryngoscope portfolio now offers two SureSight video laryngoscope solutions, including a comprehensive range of 10 blades of different sizes. The breadth of Ambu’s video laryngoscope portfolio ensures that clinicians have a SureSight video laryngoscope for every setting, scenario, and preference – obtaining flexibility, reliability, and confidence across the continuum of care.
Ambu will now engage in a controlled market release phase, collaborating with clinicians at key hospitals across the U.S. and Great Britain, to evaluate the performance of the SureSight Mobile in clinical settings. Subsequently, Ambu will engage in a full launch in 2026.
“With the launch of SureSight Mobile, Ambu is reinforcing our leadership in the respiratory market. By expanding our portfolio with a mobile video laryngoscope solution, we are addressing the needs clinicians face during unexpected intubation – when time matters most. This innovation reflects our commitment to delivering a comprehensive respiratory offering of advanced solutions that empower healthcare professionals to make fast, confident decisions and uphold the highest standards of care across clinical settings,” Ambu CEO Britt Meelby Jensen said.
